erythrosine has been researched along with n(alpha)-(4-amino-4-deoxy-n(10)--methylpteroyl-n(epsilon)-4'-fluoresceinthiocarbamoyl)-l-lysine trihydrate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertino, JR; Elisseyeff, Y; Flintoff, WF; Goker, E; Gorlick, R; Mazumdar, M; Steinherz, P; Trippett, T | 1 |
1 other study(ies) available for erythrosine and n(alpha)-(4-amino-4-deoxy-n(10)--methylpteroyl-n(epsilon)-4'-fluoresceinthiocarbamoyl)-l-lysine trihydrate
| Article | Year |
|---|---|
Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
Topics: Adolescent; Adult; Aged; Biological Transport; Blast Crisis; Carrier Proteins; Child; Child, Preschool; Drug Resistance; Fluoresceins; Folic Acid; Humans; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reduced Folate Carrier Protein | 1997 |